News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
623,010 Results
Type
Article (47593)
Company Profile (225)
Press Release (575192)
Multimedia
Podcasts (73)
Webinars (8)
Section
Business (172973)
Career Advice (1730)
Deals (30775)
Drug Delivery (101)
Drug Development (72453)
Employer Resources (136)
FDA (15657)
Job Trends (14099)
News (299232)
Policy (30254)
Tag
Academia (2696)
Academic (1)
Accelerated approval (6)
Adcomms (18)
Allergies (92)
Alliances (43276)
ALS (93)
Alzheimer's disease (1316)
Antibody-drug conjugate (ADC) (135)
Approvals (15671)
Artificial intelligence (276)
Autoimmune disease (26)
Automation (16)
Bankruptcy (278)
Best Places to Work (11457)
BIOSECURE Act (11)
Biosimilars (94)
Biotechnology (165)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (291)
Cancer (2295)
Cardiovascular disease (188)
Career advice (1456)
Career pathing (26)
CAR-T (150)
Cell therapy (425)
Cervical cancer (22)
Clinical research (59241)
Collaboration (843)
Company closure (1)
Compensation (497)
Complete response letters (18)
COVID-19 (2486)
CRISPR (49)
C-suite (253)
Cystic fibrosis (100)
Data (2280)
Decentralized trials (2)
Denatured (28)
Depression (44)
Diabetes (271)
Diagnostics (6054)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (34)
Drug discovery (119)
Drug pricing (116)
Drug shortages (30)
Duchenne muscular dystrophy (91)
Earnings (68882)
Editorial (39)
Employer branding (18)
Employer resources (119)
Events (95994)
Executive appointments (737)
FDA (17019)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (728)
Gene editing (116)
Generative AI (23)
Gene therapy (312)
GLP-1 (722)
Government (4542)
Grass and pollen (6)
Guidances (148)
Healthcare (19095)
Huntington's disease (21)
IgA nephropathy (28)
Immunology and inflammation (114)
Indications (30)
Infectious disease (2628)
Inflammatory bowel disease (152)
Inflation Reduction Act (7)
Influenza (52)
Intellectual property (93)
Interviews (277)
IPO (14743)
IRA (45)
Job creations (3115)
Job search strategy (1271)
Kidney cancer (11)
Labor market (34)
Layoffs (386)
Leadership (14)
Legal (6597)
Liver cancer (75)
Lung cancer (328)
Lymphoma (154)
Machine learning (8)
Management (43)
Manufacturing (295)
MASH (69)
Medical device (14042)
Medtech (14046)
Mergers & acquisitions (16602)
Metabolic disorders (689)
Multiple sclerosis (79)
NASH (17)
Neurodegenerative disease (93)
Neuropsychiatric disorders (23)
Neuroscience (1849)
NextGen: Class of 2025 (6395)
Non-profit (4391)
Now hiring (27)
Obesity (362)
Opinion (213)
Ovarian cancer (73)
Pain (94)
Pancreatic cancer (87)
Parkinson's disease (141)
Partnered (21)
Patents (228)
Patient recruitment (115)
Peanut (47)
People (51846)
Pharmaceutical (49)
Pharmacy benefit managers (18)
Phase I (18117)
Phase II (26017)
Phase III (20000)
Pipeline (1294)
Policy (142)
Postmarket research (2353)
Preclinical (7536)
Press Release (55)
Prostate cancer (105)
Psychedelics (29)
Radiopharmaceuticals (256)
Rare diseases (369)
Real estate (4861)
Recruiting (55)
Regulatory (21227)
Reports (34)
Research institute (2378)
Resumes & cover letters (260)
Rett syndrome (5)
RNA editing (3)
RSV (40)
Schizophrenia (72)
Series A (127)
Series B (87)
Service/supplier (5)
Sickle cell disease (54)
Special edition (19)
Spinal muscular atrophy (149)
Sponsored (28)
Startups (3275)
State (1)
Stomach cancer (14)
Supply chain (66)
Tariffs (46)
The Weekly (43)
Vaccines (658)
Venture capitalists (34)
Weight loss (243)
Women's health (34)
Worklife (14)
Date
Last 7 days (908)
Last 30 days (2887)
Last 365 days (31482)
2025 (11445)
2024 (34176)
2023 (38815)
2022 (49630)
2021 (53738)
2020 (51984)
2019 (45390)
2018 (34223)
2017 (30334)
2016 (29104)
2015 (33855)
2014 (25527)
2013 (21192)
2012 (22823)
2011 (23369)
2010 (22064)
Location
Africa (735)
Alabama (43)
Alaska (5)
Arizona (190)
Arkansas (14)
Asia (37418)
Australia (6505)
California (6075)
Canada (1930)
China (519)
Colorado (280)
Connecticut (290)
Delaware (151)
Europe (83906)
Florida (899)
Georgia (199)
Hawaii (1)
Idaho (52)
Illinois (524)
India (26)
Indiana (323)
Iowa (9)
Japan (169)
Kansas (89)
Kentucky (24)
Louisiana (12)
Maine (45)
Maryland (933)
Massachusetts (4672)
Michigan (175)
Minnesota (389)
Mississippi (2)
Missouri (82)
Montana (31)
Nebraska (22)
Nevada (63)
New Hampshire (69)
New Jersey (1742)
New Mexico (28)
New York (1690)
North Carolina (1039)
North Dakota (9)
Northern California (2750)
Ohio (190)
Oklahoma (13)
Oregon (35)
Pennsylvania (1323)
Puerto Rico (14)
Rhode Island (30)
South America (1041)
South Carolina (25)
South Dakota (1)
Southern California (2227)
Tennessee (101)
Texas (904)
United States (23018)
Utah (189)
Virginia (141)
Washington D.C. (63)
Washington State (540)
West Virginia (3)
Wisconsin (58)
623,010 Results for "nu med plus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NUS researchers develop microneedle technology to accelerate diabetic wound healing
March 26, 2025
·
5 min read
Business
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),
March 21, 2024
·
2 min read
Press Releases
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
April 9, 2025
·
3 min read
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
BioMidwest
Nu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC Regions
Nu-Tek BioSciences is an innovative manufacturer of critical raw materials used in cell culture media for the development and manufacturing of pharmaceuticals.
June 4, 2024
·
3 min read
Press Releases
NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment
January 24, 2025
·
4 min read
Lung cancer
Summit’s Bispecific Beats Yet Another Cancer Med, Pressuring Keytruda’s ‘Supremacy’
Analysts at BMO Capital Markets expect Summit and Akeso’s HARMONi-6 readout to put some pressure on Merck and its blockbuster biologic Keytruda.
April 23, 2025
·
2 min read
·
Tristan Manalac
Weight Loss
Viking Rises as Pfizer’s Oral Obesity Med Falters
Viking Therapeutics enjoyed a nice share rally on the news that rival Pfizer is discontinuing obesity candidate danuglipron. But the biotech has a long way to go to recover after six straight months of decline.
April 14, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Boditech Med and SphingoTec Announce Launch of AFIAS penKid(R) Assay for Kidney Function Diagnostics
May 6, 2025
·
5 min read
Press Releases
NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields
January 7, 2025
·
5 min read
1 of 62,301
Next
